These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20594226)

  • 1. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice.
    Lee BJ; Kim JS; Kim BK; Jung SJ; Joo MK; Hong SG; Kim JS; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT; Yoo HS; Oh S
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1105-10. PubMed ID: 20594226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezetimibe prevents cholesterol gallstone formation in mice.
    Zúñiga S; Molina H; Azocar L; Amigo L; Nervi F; Pimentel F; Jarufe N; Arrese M; Lammert F; Miquel JF
    Liver Int; 2008 Aug; 28(7):935-47. PubMed ID: 18783541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
    Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
    Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
    Xu G; Zhao L; Fuchs M
    Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations.
    Johnson VJ; He Q; Osuchowski MF; Sharma RP
    Toxicology; 2004 Sep; 201(1-3):67-75. PubMed ID: 15297021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice.
    Wang HH; Afdhal NH; Gendler SJ; Wang DQ
    Gastroenterology; 2006 Jul; 131(1):210-22. PubMed ID: 16831603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis.
    Lee EJ; Kim MH; Kim YR; Park JW; Park WJ
    Int J Mol Med; 2018 Mar; 41(3):1715-1723. PubMed ID: 29286073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Ceramide Decreased the Expression of ATP-Binding Cassette Transporter G5/8 mRNA in an Animal Model of Cholesterol Gallstone.
    Kim HJ; Kim JS; Oh S; Yoo HS
    Dig Dis; 2017; 35(5):439-443. PubMed ID: 28268212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
    Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
    J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice.
    Kim JK; Cho SM; Kang SH; Kim E; Yi H; Yun ES; Lee DG; Cho HJ; Paik YH; Choi YK; Haam SJ; Shin HC; Lee DK
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1745-51. PubMed ID: 22849613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
    Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
    Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.
    Park TS; Rosebury W; Kindt EK; Kowala MC; Panek RL
    Pharmacol Res; 2008 Jul; 58(1):45-51. PubMed ID: 18611440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice.
    Amigo L; Mardones P; Ferrada C; Zanlungo S; Nervi F; Miquel JF; Rigotti A
    Hepatology; 2003 Sep; 38(3):726-34. PubMed ID: 12939599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication.
    Tatematsu K; Tanaka Y; Sugiyama M; Sudoh M; Mizokami M
    J Med Virol; 2011 Apr; 83(4):587-93. PubMed ID: 21328371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
    Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
    Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI.
    Fuchs M; Ivandic B; Müller O; Schalla C; Scheibner J; Bartsch P; Stange EF
    Hepatology; 2001 Jun; 33(6):1451-9. PubMed ID: 11391534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of sphingolipid metabolism and pSTAT3 expression by dietary cholesterol in the gallbladder of hamsters.
    Shin HW; Kim D; Lee Y; Yoo HS; Lee BJ; Kim JS; Jang S; Lim H; Lee Y; Oh S
    Arch Pharm Res; 2009 Sep; 32(9):1253-62. PubMed ID: 19784582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and subcellular localization of Na
    Chen Y; Wu S; Tian Y; Kong J
    J Physiol Biochem; 2017 Feb; 73(1):133-139. PubMed ID: 27822917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin-resistant obese mice have paradoxically low biliary cholesterol saturation.
    Tran KQ; Graewin SJ; Swartz-Basile DA; Nakeeb A; Svatek CL; Pitt HA
    Surgery; 2003 Aug; 134(2):372-7. PubMed ID: 12947343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration.
    Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye KA; Stocker R; Jessup W; Garner B
    Biochem Pharmacol; 2007 May; 73(9):1340-6. PubMed ID: 17239824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.